Sumitomo Mitsui Trust Group Inc. Has $80.31 Million Position in Waters Corporation $WAT

Sumitomo Mitsui Trust Group Inc. cut its position in Waters Corporation (NYSE:WAT) by 4.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 214,145 shares of the medical instruments supplier’s stock after selling 9,179 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Waters were worth $80,313,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Brighton Jones LLC raised its holdings in Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after buying an additional 673 shares during the last quarter. Integrated Wealth Concepts LLC boosted its position in Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after buying an additional 30 shares during the period. Goldman Sachs Group Inc. grew its holdings in Waters by 3.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after acquiring an additional 6,976 shares during the last quarter. Empowered Funds LLC grew its holdings in Waters by 16.6% during the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after acquiring an additional 160 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new position in Waters in the 2nd quarter valued at approximately $232,000. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Stock Down 0.4%

Shares of NYSE:WAT opened at $411.88 on Friday. Waters Corporation has a 1 year low of $282.77 and a 1 year high of $420.26. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.86 and a quick ratio of 0.50. The business’s 50-day moving average is $377.18 and its 200-day moving average is $346.31. The company has a market capitalization of $40.47 billion, a price-to-earnings ratio of 102.71, a P/E/G ratio of 2.40 and a beta of 1.19.

Waters (NYSE:WAT) last released its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, topping the consensus estimate of $3.01 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The firm’s revenue was up 113.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Equities research analysts predict that Waters Corporation will post 14.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on WAT. Wall Street Zen downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Monday, July 20th. Weiss Ratings cut shares of Waters from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday. HSBC increased their price objective on Waters from $415.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, June 3rd. Barclays raised their target price on Waters from $425.00 to $460.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 5th. Finally, UBS Group upped their price target on Waters from $330.00 to $375.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $420.35.

Insider Activity

In other news, Director Christopher A. Kuebler sold 3,626 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the sale, the director owned 17,808 shares of the company’s stock, valued at $7,086,515.52. This trade represents a 16.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.31% of the company’s stock.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.